Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009

Occup Environ Med. 2016 Mar;73(3):187-94. doi: 10.1136/oemed-2015-103309. Epub 2016 Jan 22.

Abstract

Background: Australia is known to have had one of the highest per-capita asbestos consumption rates, yet there are few contemporary reports on malignant mesothelioma trends.

Methods: Data on 10 930 people with malignant pleural mesothelioma (MPM) and 640 people with malignant peritoneal mesothelioma diagnosed in Australia during 1982-2009 were analysed. Observed incidence rate trends were quantified. Incidence rates were projected up to 2030 using observed incident cases during 1982-2012. The relative per-decade change in excess mortality during 1999-2009 was estimated.

Results: During 1982-2009, acceleration in MPM age-standardised incidence rates were highest for women and those aged 75 years and above, with average annual percentage changes of +4.9 (95% CI 3.6 to 6.2) and +7.2 (95% CI 5.4 to 9.0), respectively. Age-standardised incidence rates for men with MPM aged 0-64 years decelerated rapidly during 2003-2009, an average annual percentage change of -5.1% (95% CI -7.6% to -2.5%). Overall, male age-specific MPM incidence rates in the age group of 65-74 year during 2010-2030 are projected to decline with rates projected to increase for older men and women with MPM. There was a statistically significant 16% relative reduction in the excess mortality rate (EMR) up to 5 years postdiagnosis for people diagnosed with malignant pleural and peritoneal mesothelioma combined in 2009 compared with those diagnosed in 1999, an EMR ratio of 0.84 (95% CI 0.77 to 0.92).

Conclusions: Australia's malignant mesothelioma incidence rates appear to have reached maximum levels but with differences over time by age, gender and tumour location. Improvements over time in survival provide a glimpse of hope for this almost invariably fatal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Asbestos / adverse effects*
  • Australia / epidemiology
  • Carcinogens*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Environmental Exposure*
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Lung / pathology
  • Lung Neoplasms / epidemiology*
  • Lung Neoplasms / mortality
  • Male
  • Mesothelioma / epidemiology*
  • Mesothelioma / mortality
  • Mesothelioma, Malignant
  • Middle Aged
  • Peritoneal Neoplasms / epidemiology*
  • Peritoneal Neoplasms / mortality
  • Peritoneum / pathology
  • Pleural Neoplasms / epidemiology*
  • Pleural Neoplasms / mortality
  • Young Adult

Substances

  • Carcinogens
  • Asbestos